Report Categories
View AllRecent Articles
View All
XBIO Xenetic Biosciences reports 31 percent narrower Q2 2025 loss than analyst estimates with shares dipping marginally following the earnings release
The strategic moves Granite GRNT is making now 175 20260508
Wendys WEN Trading Strategy Q4 2025 EPS Exceeds Expectations
NDSN Nordson Corporation posts narrow Q1 2026 EPS miss shares rise slightly on unchanged investor outlook